Compare SWX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SWX | ORMP |
|---|---|---|
| Founded | 1931 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 104.6M |
| IPO Year | N/A | N/A |
| Metric | SWX | ORMP |
|---|---|---|
| Price | $80.11 | $3.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $84.50 | N/A |
| AVG Volume (30 Days) | ★ 329.0K | 272.7K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | 157.10 | ★ 838.25 |
| EPS | ★ 6.42 | 1.03 |
| Revenue | ★ $4,649,933,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.48 | ★ $2.96 |
| Revenue Growth | ★ 41.35 | N/A |
| 52 Week Low | $64.69 | $1.82 |
| 52 Week High | $83.11 | $3.19 |
| Indicator | SWX | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 48.93 | 74.34 |
| Support Level | $79.27 | $2.66 |
| Resistance Level | $80.81 | $2.84 |
| Average True Range (ATR) | 1.42 | 0.16 |
| MACD | -0.15 | 0.03 |
| Stochastic Oscillator | 34.49 | 80.89 |
Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution and Utility Infrastructure Services units. The first of these encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. The natural gas distribution division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers. The Utility Infrastructure Services segment generates the other half of the company's total revenue from the underground piping contractor services that its subsidiary, Centuri Construction Group, provides.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.